MJH Associates today welcomed Jim Callandrillo as Executive Vice President and General Manager of HRA - Healthcare Research & Analytics, a consultative healthcare market research practice that is part of the Plainsboro, N.J.-based Michael J. Hennessy Associates, Inc. (MJH) family of businesses. HRA offers quantitative and qualitative, custom and multi-client primary market research services to support the business needs of the pharmaceutical, biotech and medical device markets.
CURE® Magazine and the Foundation for Women’s Cancer have teamed up in CURE’s Advocacy Spotlight Partnership program to battle women’s cancer through education and shared advocacy on behalf of women suffering from below-the-belt women’s cancers.
Early results of widespread adoption of the Patient-Centered Medical Home (PCMH) model within the Veterans’ Health Administration did not show evidence of improved patient satisfaction, one of the model’s core aims, according to a study published this month in The American Journal of Managed Care.
U.S. News & World Report, a nationally recognized publisher of healthcare consumer advice and information, and Pharmacy Times, the pharmacy industry’s No. 1 trusted print and online resource, today released the 2015 Top Recommended Health Products. Consumers and healthcare professionals can now visit U.S. News Health and www.otcguide.net to see the collective recommendations of thousands of pharmacists for more than 1,100 over-the-counter brands in 168 product categories.
A recognition program launched this year to coincide with the 20th year of The American Journal of Managed Care will be named the Seema S. Sonnad Emerging Leader in Managed Care Research Award. The award will honor the journal’s longtime associate editor, who died of a cardiac arrhythmia she suffered while running an ultramarathon May 27, 2015, in Washington State.
CURE® Magazine, the largest consumer publication in the United States focused entirely on cancer, today announced that two leading advocacy groups for patients with melanoma, AIM at Melanoma and the Melanoma Research Foundation (MRF), have joined CURE’s Advocacy Spotlight Partnership Program to battle the deadly skin cancer together.